46 related articles for article (PubMed ID: 17090981)
1. Quality of Life Variables Assessment, Before and After Pancreatoduodenectomy (PD): Prospective Study.
Arvaniti M; Danias N; Theodosopoulou E; Smyrniotis V; Karaoglou M; Sarafis P
Glob J Health Sci; 2015 Nov; 8(6):203-10. PubMed ID: 26755486
[TBL] [Abstract][Full Text] [Related]
2. Determining the Minimal Clinically Important Difference of the Functional Assessment of Cancer Therapy Hepatobiliary Questionnaire to Evaluate the Change in the Quality of Life of Patients With Pancreatic Cancer During Radiation Therapy.
Zaniletti I; Gunn HJ; Hallemeier CL; Laughlin BS; Leavitt TR; Haddock MG; Merrell KW; Leenstra JL; May BC; Ashman JB; DeWees TA
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):137-141. PubMed ID: 37586614
[No Abstract] [Full Text] [Related]
3. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ducreux M; Cuhna AS; Caramella C; Hollebecque A; Burtin P; Goéré D; Seufferlein T; Haustermans K; Van Laethem JL; Conroy T; Arnold D;
Ann Oncol; 2015 Sep; 26 Suppl 5():v56-68. PubMed ID: 26314780
[No Abstract] [Full Text] [Related]
4. Timing of start of systemic treatment in patients with asymptomatic metastasized pancreatic cancer (TIMEPAN): a protocol of a multicenter prospective patient preference non-randomized trial.
Augustinus S; Broekman T; Creemers GJ; Daamen LA; van Dieren S; de Groot JB; Cirkel GA; Homs MYV; van Laarhoven HWM; van Leeuwen L; Los M; Luelmo SAC; van Oijen MGH; Spierings LEAM; de Vos-Geelen J; Besselink MG; Wilmink JW;
Acta Oncol; 2023 Dec; 62(12):1973-1978. PubMed ID: 37897803
[No Abstract] [Full Text] [Related]
5. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Conroy T; Pfeiffer P; Vilgrain V; Lamarca A; Seufferlein T; O'Reilly EM; Hackert T; Golan T; Prager G; Haustermans K; Vogel A; Ducreux M;
Ann Oncol; 2023 Nov; 34(11):987-1002. PubMed ID: 37678671
[No Abstract] [Full Text] [Related]
6. [Adjuvant and additive therapy for cancer of the pancreas].
Neoptolemos JP; Raraty MG; Ghaneh P; Hickey H; Stocken DD; Dunn JA; Friess H; Büchler MW
Chirurg; 2003 Mar; 74(3):191-201. PubMed ID: 12647075
[TBL] [Abstract][Full Text] [Related]
7. Effect of combined treatment methods on quality of life in patients with pancreatic cancer.
Heras P; Kritikos K; Hatzopoulos A; Kritikos N; Karagiannis S; Mitsibounas D
Am J Ther; 2009; 16(4):316-8. PubMed ID: 19455022
[TBL] [Abstract][Full Text] [Related]
8. The effect of combined treatment methods on survival and toxicity in patients with pancreatic cancer.
Brasiūniene B; Juozaityte E
Medicina (Kaunas); 2007; 43(9):716-25. PubMed ID: 17986845
[TBL] [Abstract][Full Text] [Related]
9. Impact of different treatment methods on survival in advanced pancreatic cancer.
Brasiūniene B; Juozaityte E; Barauskas G
Medicina (Kaunas); 2005; 41(5):382-5. PubMed ID: 15947521
[TBL] [Abstract][Full Text] [Related]
10. Impact of gemcitabine chemotherapy and 3-dimensional conformal radiation therapy/5-fluorouracil on quality of life of patients managed for pancreatic cancer.
Short M; Goldstein D; Halkett G; Reece W; Borg M; Zissiadis Y; Kneebone A; Spry N
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):157-62. PubMed ID: 22543205
[TBL] [Abstract][Full Text] [Related]
11. [Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective].
Wilkowski R; Thoma M; Heinemann V; Rau HG; Wagner A; Stoffregen C; Dühmke E
Strahlenther Onkol; 2003 Feb; 179(2):78-86. PubMed ID: 12590317
[TBL] [Abstract][Full Text] [Related]
12. [Effect of combined treatment methods on quality of life in patients with pancreatic cancer].
Brasiūniene B; Brasiūnas V; Juozaityte E
Medicina (Kaunas); 2006; 42(10):817-22. PubMed ID: 17090981
[TBL] [Abstract][Full Text] [Related]
13. [Chemoradiation for pancreatic adenocarcinoma].
Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
